MODERNA INC (MRNA) - Price, trends, fundamentals and chart - Passport to Wall Street

MODERNA INC (NASDAQ: MRNA)

Overview

current price

$193.24

$193.24

change

0.17 | 0.09%

0.17 | 0.09%

Yesterday's Close

193.07

open

194.43

volume

2.39 M

30d. avg volume.

6.34 M

1 day

187.55 - 195.00

52 weeks

115.03 - 217.25

p/e

6.96

beta

1.7112

market cap

74.17 B

dividend yield

0.00%

Industry

-

News and Commentary

FDA Says COVID Vaccines Will Most Likely Need Annual Update The Food and Drug Administration (FDA) on Monday published a proposed new COVID vaccine strategy as the coronavirus pandemic continues to evolve beyond the crisis of an emerging...

Market Update: Dow Falls 600 Points on Disappointing December Retail Sales Stocks fell lower on Wednesday as more disappointing economic data and corporate news weighed on market sentiment as investors fear a potential recession. The Dow Jones Industria...

Novo Nordisk’s Obesity Drug Shows Stunning Results in Clinical Trials The last medical breakthrough that had an immediate real-world impact was the mRNA vaccines from Pfizer

Market Update: Stocks Climb on Better-than-Expected November CPI Report Stocks rose Tuesday after the release of new U.S. inflation data showed prices rose at a less-than-expected rate last month. The Dow Jones Industrial Average climbed over 100 poi...

FDA, CDC Sign Off on Omicron Vaccines for Children as Young as 6 Months Old U.S. federal regulators have authorized updated Omicron COVID vaccines for children as young as 6 months old, allowing pharmacies and health care providers to start administering...

CDC Recommends Novavax COVID Shots as Mix-and-Match Third Dose Booster The U.S. Centers for Disease Control and Prevention (CDC) recommended Novavax

CDC, FDA Sign Off on Updated COVID Booster Shots for Children The U.S. Centers for Disease Control and Prevention (CDC) on Wednesday recommended updated Omicron-targeting COVID boosters for Americans as young as 5-years-old, seeking to incr...

Pfizer, Moderna Seek FDA Authorization for Bivalent COVID Boosters for Younger Americans Younger children may soon be eligible to receive an Omicron-target booster shot later this year, following U.S. Food and Drug Administration (FDA) applications from Pfizer ...

FDA Authorizes Updated COVID Boosters Targeting Omicron The U.S. Food and Drug Administration (FDA) this week authorized updated COVID boosters from Pfizer

CDC Eases COVID Guidelines for Quarantine, Marking New Phase of Pandemic The U.S. Centers for Disease Control and Prevention (CDC) has recently eased its COVID-19 guidance...

StockTwits

Join now and unlock premium features

Access to premium stock and ETF data including financials, holdings and more
Participate in trading contests and earn real prizes
Sync you favorite articles and symbols between all of your device
And much more